Western Sydney University’s NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people. The trial’s results, published in the journal Alzheimer’s and Dementia, signal the efficacy and safety of Sailuotong (SLT), a novel herbal extract, as a potential treatment for MCI.